Cytomegalovirus retinitis in children post hematopoietic stem cell transplantation: Can we develop a screening protocol?

Cytomegalovirus retinitis in children post hematopoietic stem cell transplantation: Can we develop a screening protocol?

Bibliographic Details
Main Authors:	Nouf Al-Farsi, Samira Al Jabri
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2022-01-01
Series:	Oman Journal of Ophthalmology
Online Access:	http://www.ojoonline.org/article.asp?issn=0974-620X;year=2022;volume=15;issue=1;spage=1;epage=2;aulast=Al-Farsi

Similar Items

Cytomegalovirus Infection Post-hematopoietic Stem Cell Transplant: Incidence, Risk Factors, and Outcome in an Omani Cohort
by: Fatma Al Farsi, et al.
Published: (2023-11-01)

Analysis of Clinical Characteristics of Patients with Recurrent Cytomegalovirus Retinitis after Hematopoietic Stem Cell Transplantation
by: Xiaona Wang, et al.
Published: (2023-04-01)

Detection of Cytomegalovirus in Post Hematopoietic Stem Cells Transplant Recipients by Real-Time PCR
by: Saifullah Khan Niazi, et al.
Published: (2023-10-01)

Amblyopia update: What we know and what can we do?
by: Humaid Al-Kalbani, et al.
Published: (2024-01-01)

Incontinentia pigmenti: What we know and can we manage it as retinopathy of prematurity?
by: Nouf Al-Farsi, et al.
Published: (2022-01-01)

Total Body Irradiation for Hematopoietic Stem Cell Transplantation: What Can We Agree on?
by: Mitchell Sabloff, et al.
Published: (2021-02-01)

The Ten Most Common Questions on Cytomegalovirus Infection in Hematopoietic Stem Cell Transplant Patients
by: Johnny Zakhour, et al.
Published: (2022-12-01)

Efficacy and safety of letermovir prophylaxis for cytomegalovirus infection after hematopoietic stem cell transplantation
by: Wen-Wen Li, et al.
Published: (2024-01-01)

Risk factors of cytomegalovirus infection in patients after allogeneic hematopoietic stem cells transplantation
by: D. N. Balashov, et al.
Published: (2022-11-01)

Cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation: clinical significance and definitions
by: A. A. Dmitrova, et al.
Published: (2022-06-01)

Antiviral therapy defiant mixed viral retinitis post hematopoietic allogeneic stem cell transplant
by: Nadia Gabarin, et al.
Published: (2023-03-01)

Association Between Cytomegalovirus and Epstein-Barr Virus Co-Reactivation and Hematopoietic Stem Cell Transplantation
by: Shan-shan Li, et al.
Published: (2022-03-01)

P1617: CLINICAL SIGNIFICANCE OF CYTOMEGALOVIRUS DRUG RESISTANCE GENE MUTATIONS IN CYTOMEGALOVIRUS INFECTION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
by: D. yang, et al.
Published: (2022-06-01)

Construction of a nursing care protocol for children in post-hematopoietic stem cell transplantation
by: Jéssica Alline Pereira Rodrigues, et al.
Published: (2022-05-01)

Clinical significance of human cytomegalovirus viruria and the effect of antiviral therapy in hematopoietic stem cell transplant recipients
by: Wei-Lu, et al.
Published: (2019-06-01)

Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant
by: Susan E. Prockop, et al.
Published: (2023-05-01)

Another tool against cytomegalovirus after allogeneic hematopoietic cell transplantation
by: George L. Chen, et al.
Published: (2023-05-01)

Surveillance over cytomegalovirus (CMV) reactivation following hematopoietic stem cell transplantation: a single-center experience
by: Zhivka Stoykova, et al.
Published: (2024-12-01)

Cytomegalovirus-specific neutralizing antibodies effectively prevent uncontrolled infection after allogeneic hematopoietic stem cell transplantation
by: Huiru Wang, et al.
Published: (2022-10-01)

Monitoring of resistanceassociated mutations in UL97 gene of cytomegalovirus in children after allogeneic hematopoietic stem cell transplantation
by: Kozhushnaya O.S., et al.
Published: (2022-03-01)

Avatrombopag for the treatment of thrombocytopenia post hematopoietic stem-cell transplantation
by: Meng Zhou, et al.
Published: (2022-09-01)

Allogeneic hematopoietic stem cell transplantation in China: where we are and where to go
by: Lv Meng, et al.
Published: (2012-03-01)

Intrathecal cytomegalovirus immunoglobulin for CMV encephalitis post allogeneic stem cell transplantation
by: Ian Pang, et al.
Published: (2022-01-01)

Genetic Variants Associated with Drug Resistance of Cytomegalovirus in Hematopoietic Cell Transplantation Recipients
by: Seungwan Chae, et al.
Published: (2023-05-01)

Evaluation of Platelet Parameters in Patients With Secondary Failure of Platelet Recovery and Cytomegalovirus Infection After Hematopoietic Stem Cell Transplantation
by: Yujian Zhao B.S., et al.
Published: (2023-02-01)

Investigation of Cytomegalovirus, Epstein-Barr Virus and Adenovirus Infections After Hematopoietic Stem Cell Transplantation (HSCT) in Pediatric Patients
by: Nazlı Nida KAYA, et al.
Published: (2018-03-01)

Haploidentical Hematopoietic Stem Cell Transplantation Followed by ‘Post-Cyclophosphamide’: The Future of Allogeneic Stem Cell Transplant
by: Samuel Cytryn, et al.
Published: (2020-04-01)

Transplant-Associated Thrombotic Microangiopathy in the Context of Allogenic Hematopoietic Stem Cell Transplantation: Where We Stand
by: Ioanna Lazana
Published: (2023-01-01)

Features of cytomegalovirus infection and evaluation of cytomegalovirus-specific T cells therapy in children’s patients following allogeneic hematopoietic stem cell transplantation: A retrospective single-center study
by: Yongsheng Ruan, et al.
Published: (2022-10-01)

Post‐hematopoietic stem cell transplantation relapse: Role of checkpoint inhibitors
by: Elham Roshandel, et al.
Published: (2022-03-01)

Vaccination post-allogeneic hematopoietic stem cell transplantation: what is feasible?
by: Anne Conrad, et al.
Published: (2018-04-01)

Persistence of KIRneg NK cells after haploidentical hematopoietic stem cell transplantation protects from human cytomegalovirus infection/reactivation
by: Clara Di Vito, et al.
Published: (2024-01-01)

Association between Antiviral Prophylaxis and Cytomegalovirus and Epstein–Barr Virus DNAemia in Pediatric Recipients of Allogeneic Hematopoietic Stem Cell Transplant
by: Ndeye Soukeyna Diop, et al.
Published: (2021-06-01)

A Predicted Model for Refractory/Recurrent Cytomegalovirus Infection in Acute Leukemia Patients After Haploidentical Hematopoietic Stem Cell Transplantation
by: Meng-Zhu Shen, et al.
Published: (2022-03-01)

Treatment of cytomegalovirus retinitis
by: B. S. Pershin, et al.
Published: (2019-11-01)

Hematopoietic stem cell protocols /
by: Bunting, Kevin D.
Published: (2008)

Post-transplant cyclophosphamide or cell selection in haploidentical allogeneic hematopoietic cell transplantation?
by: Razan Mohty, et al.
Published: (2024-12-01)

Human Stem Cell Transplantation for Retinal Degenerative Diseases: Where Are We Now?
by: Ignacio Alcalde, et al.
Published: (2022-01-01)

Donor-derived cytomegalovirus-cytotoxic T lymphocytes and leflunomide successfully control refractory cytomegalovirus infections and disease of multiple sites after allogeneic-hematopoietic stem cell transplantation: A case report
by: Nan Su, et al.
Published: (2022-09-01)

Treatment of recurrent pediatric myelodysplastic syndrome post hematopoietic stem cell transplantation
by: Franziska Wachter, et al.
Published: (2023-11-01)